A: The Commission's independence rules apply to audits of financial statements required by SEC rules, except for those required by Rule 3-05 and 3-14 of Regulation S-X and Item 310(c) and (e) of Regulation S-B.
1 The Centers for Disease Control and Prevention (CDC) recommends 2 doses of quadrivalent meningococcal conjugate vaccine for adolescents 11 through 18 years of age.  The first dose should be given at 11 or 12 years of age, followed by a booster dose at age 16.
CDC recommends a meningococcal conjugate vaccine (MenactraÂ® or MenveoÂ®) for children who are between 2 months and 10 years old, if they: 1  Have a rare type of disorder (complement component deficiency) 2  Are taking the medicine called SolirisÂ®. 3  Have a damaged spleen or their spleen has been removed. 4  Have HIV.